129 related articles for article (PubMed ID: 2128469)
1. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. II. Phospholipase A2 inhibitors induce T cell hybridomas and a T cell clone for the formation of glycosylation-inhibiting factor.
Ohno H; Iwata M; Katamura K; Ishizaka K
Int Immunol; 1990; 2(3):257-66. PubMed ID: 2128469
[TBL] [Abstract][Full Text] [Related]
2. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. I. Phospholipase A2 inhibitors exert similar immunological activities as glycosylation inhibiting factor.
Ohno H; Iwata M; Nakamura T; Ishizaka K
Int Immunol; 1989; 1(4):425-33. PubMed ID: 2535136
[TBL] [Abstract][Full Text] [Related]
3. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
Iwata M; Katamura K; Kubo RT; Ishizaka K
J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation.
Iwata M; Adachi M; Ishizaka K
J Immunol; 1988 Apr; 140(8):2534-42. PubMed ID: 3258613
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.
Iwata M; Huff TF; Ishizaka K
J Immunol; 1984 Mar; 132(3):1286-93. PubMed ID: 6363537
[TBL] [Abstract][Full Text] [Related]
7. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
Iwata M; Ishizaka K
J Immunol; 1988 Nov; 141(10):3270-7. PubMed ID: 2460527
[TBL] [Abstract][Full Text] [Related]
8. Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
Gomi H; Tagaya Y; Nakano T; Mikayama T; Ishizaka K
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2824-8. PubMed ID: 7511819
[TBL] [Abstract][Full Text] [Related]
9. IgE-binding factors and regulation of the IgE antibody response.
Ishizaka K
Annu Rev Immunol; 1988; 6():513-34. PubMed ID: 3289576
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor.
Iwata M; Akasaki M; Ishizaka K
J Immunol; 1984 Sep; 133(3):1505-12. PubMed ID: 6431000
[TBL] [Abstract][Full Text] [Related]
11. Relationship between T cell receptors and antigen-binding factors. II. Common antigenic determinants and epitope recognition shared by T cell receptors and antigen-binding factors.
Iwata M; Katamura K; Kubo RT; Grey HM; Ishizaka K
J Immunol; 1989 Dec; 143(12):3917-24. PubMed ID: 2480379
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
Nakano T; Ishii Y; Ishizaka K
J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
[TBL] [Abstract][Full Text] [Related]
13. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
Jardieu P; Uede T; Ishizaka K
J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
[TBL] [Abstract][Full Text] [Related]
15. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the biologic activities of IgE-binding factors. VII. Biochemical mechanisms by which glycosylation-enhancing factor activates phospholipase in lymphocytes.
Akasaki M; Iwata M; Ishizaka K
J Immunol; 1985 Jun; 134(6):4069-77. PubMed ID: 3872909
[TBL] [Abstract][Full Text] [Related]
17. Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses.
Yamaguchi K; Mori A; Ohno H; Tagaya Y; Ishizaka K
Int Immunol; 1992 Mar; 4(3):337-46. PubMed ID: 1373642
[TBL] [Abstract][Full Text] [Related]
18. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
Jardieu P; Akasaki M; Ishizaka K
J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554
[TBL] [Abstract][Full Text] [Related]
19. A method to generate antigen-specific suppressor T cells in vitro from peripheral blood T cells of honey bee venom-sensitive, allergic patients.
Carini C; Iwata M; Warner J; Ishizaka K
J Immunol Methods; 1990 Mar; 127(2):221-33. PubMed ID: 2138201
[TBL] [Abstract][Full Text] [Related]
20. In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors.
Iwata M; Ishizaka K
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2444-8. PubMed ID: 2951740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
